Myriad Genetics, Inc. Announces Upcoming Investor Event

SALT LAKE CITY, Dec. 5, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it will be hosting an investor event for research analysts and institutional investors on Thursday, December 12, 2013 at 8:30 p.m. EST in San Antonio, Texas. Mark Capone, president of Myriad Genetic Laboratories; Richard Wenstrup M.D., chief medical officer; John Ryan, senior director of operations; and Larry Geier M.D., assistant professor at Kansas University Medical School will be presenting at the event. The focus of the meeting will be on Myriad's new myRisk Hereditary Cancer™ test. If you are interested in attending please contact Myriad's investor relations team for the event details.

Help employers find you! Check out all the jobs and post your resume.